無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

先進的創傷治療の世界市場の分析と予測 (2018-2024年):ドレッシング材・NPWTデバイス・生物製剤・HBOTデバイス・超音波デバイス・電磁デバイス

Global Advanced Wound Care Market: Focus on Advanced Wound Care Dressings, NPWT Devices, Wound Care Biologics, HBOT Devices, Ultrasonic Devices, and Electromagnetic Devices - Analysis and Forecast, 2018-2024

発行 BIS Research Inc. 商品コード 474945
出版日 ページ情報 英文 206 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
先進的創傷治療の世界市場の分析と予測 (2018-2024年):ドレッシング材・NPWTデバイス・生物製剤・HBOTデバイス・超音波デバイス・電磁デバイス Global Advanced Wound Care Market: Focus on Advanced Wound Care Dressings, NPWT Devices, Wound Care Biologics, HBOT Devices, Ultrasonic Devices, and Electromagnetic Devices - Analysis and Forecast, 2018-2024
出版日: 2019年08月30日 ページ情報: 英文 206 Pages
概要

世界の先進的創傷治療の市場は2024年には110億5930万ドルの規模に成長すると予測されています。

当レポートでは、世界の先進的創傷治療の市場を調査し、産業の発展の経緯、サプライチェーン、法規制上の枠組み、市場成長への各種影響因子の分析、企業および企業間の展開・戦略、競合環境と市場シェア、製品・創傷区分・地域/主要国別の動向と市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

エグゼクティブサマリー

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 産業分析

  • 産業の進化
  • 創傷治療コスト・サプライチェーン分析
  • 法規制上の枠組み

第5章 競合環境

  • ベンダーシェア分析
  • 主な戦略・展開
    • 製品投入・アップデート
    • M&A
  • 製品マッピング
  • 競合ベンチマークマッピング

第6章 世界の先進的創傷治療市場の分析・予測:製品別

  • 概要
  • ドレッシング材
    • フィルムドレッシング材
    • フォームドレッシング材
    • ハイドロファイバードレッシング材
    • ハイドロコロイドドレッシング材
    • ハイドロゲルドレッシング材
    • コラーゲンドレッシング材
    • アルギン酸ドレッシング材
    • 抗菌ドレッシング材
  • 陰圧創傷治療 (NPWTデバイス)
    • 従来型デバイス
      • キャニスター
      • ポンプ
      • ドレッシングキット
    • 単回利用デバイス
  • 生物学的製剤
    • 皮膚代替物
      • 同種移植片
      • 異種移植片
      • 胎盤・羊膜組織
      • 生体工学による人工皮膚/合成代替物
    • 増殖因子
    • 局所剤
  • その他
    • 高圧酸素療法
    • 超音波ミスト・電気刺激装置

第7章 世界の先進的創傷治療市場の分析・予測:創傷タイプ別

  • 概要
  • 慢性創傷
    • 褥瘡 (PU)
    • 静脈性下腿潰瘍 (VLU)
    • 糖尿病足潰瘍 (DFU)
  • 急性創傷

第8章 世界の先進的創傷治療市場の分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 企業プロファイル

  • 3M
  • Acelity
  • B. Braun
  • Coloplast A/S
  • ConvaTec Group Plc
  • Essity Aktiebolag
  • Integra LifeSciences Corporation
  • Medline Industries, Inc.
  • Molnlycke Health Care AB
  • MIMEDX GROUP, INC.
  • Organogenesis Inc.
  • Osiris Therapeutics Inc.
  • PAUL HARTMANN AG
  • Smith & Nephew Plc
図表

List of Tables

  • Table 3.1: Research Parameters
  • Table 4.1: Reimbursement Situation for NPWT in Europe
  • Table 5.1: Product Launch and Updates
  • Table 5.2: Mergers and Acquisitions
  • Table 6.1: Major Film Dressings, by brand, by, manufacturer
  • Table 6.2: Major Foam Dressings, by brand, by manufacturer
  • Table 6.3: Major Hydrocolloid Dressings, by brand, by manufacturer
  • Table 6.4: Major Hydrogel Dressings, by brand, by manufacturer
  • Table 6.5: Major Collagen Dressings, by brand, by manufacturer
  • Table 6.6: Major Alginate Dressings, by brand, by manufacturer
  • Table 6.7: Major Antimicrobial Dressings, by brand, by manufacturer
  • Table 7.1: Major Wound Types
  • Table 7.2: Global Pressure Ulcer Statistics
  • Table 7.3: Global Venous Leg Ulcer Statistics
  • Table 7.4: Global Diabetes Statistics
  • Table 7.5: Global Diabetic Foot Ulcer Statistics

List of Figures

  • Figure 1: Global Advanced Wound Care Market, 2018-2024
  • Figure 2: Advanced Wound Care, Market Share 2018
  • Figure 3: Advanced Wound Care Technology Products, 2018 and 2024
  • Figure 4: Growth Share Matrix, Advanced Wound Care Technology, by Product segments
  • Figure 5: Expected Growth Rates, Advanced Wound Care Technology, by Sub-Product segments
  • Figure 6: Advanced Wound Dressing, Market Share 2018
  • Figure 7: Negative Pressure Wound Therapies, Market Share 2018
  • Figure 8: Wound Biologics, Market Share 2018
  • Figure 9: Advanced Wound Care Market, by regions, 2018 and 2024
  • Figure 10: Growth Share Matrix, Advanced Wound Care Technology, by Countries
  • Figure 2.1: Advanced Wound Care: Market Segmentation
  • Figure 4.1: Industry Trends in Advanced Wound Care Market
  • Figure 4.2: Cost Breakup, Wound Management Life Cycle
  • Figure 5.1: Advanced Wound Care, Market Share 2018
  • Figure 5.2: Advanced Wound Care, Market Share 2024
  • Figure 5.3: Advanced Wound Care Market, Key Developments, 2016-2019
  • Figure 5.4: Advanced Wound Care Market, Activity Instances by Companies, 2016-2019
  • Figure 5.5: Growth Share Matrix, by Companies
  • Figure 6.1: Global Advanced Wound Care Market, 2018-2024
  • Figure 6.2: Advanced Wound Care Technology Products
  • Figure 6.3: Advanced Wound Care Technology Products
  • Figure 6.4: Global Advanced Wound Dressing Market, 2018-2024
  • Figure 6.5: Global Advanced Dressings Market, by Types
  • Figure 6.6: Advanced Wound Dressing, Market Share 2018
  • Figure 6.7: Advanced Wound Dressing, Market Share 2024
  • Figure 6.8: Global Film Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.9: Global Foam Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.10: Global Hydrofiber Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.11: Global Hydrocolloids Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.12: Global Hydrogel Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.13: Global Collagen Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.14: Global Alginate Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.15: Global Antimicrobial Advanced Wound Dressing Market ($Million), 2018-2024
  • Figure 6.16: Global Negative Pressure Wound Therapies Market ($Million), 2018 and 2024
  • Figure 6.17: Negative Pressure Wound Therapies, Market Share 2018
  • Figure 6.18: Negative Pressure Wound Therapies, Market Share 2024
  • Figure 6.19: Global Conventional NPWT Market ($Million), 2018-2024
  • Figure 6.20: Global Single Use NPWT Market ($Million), 2018-2024
  • Figure 6.21: Global Wound Biologics Market ($Million), 2018 and 2024
  • Figure 6.22: Wound Biologics, Market Share 2018
  • Figure 6.23: Wound Biologics, Market Share 2024
  • Figure 6.24: Global Skin/Dermal Substitutes Market, 2018-2024
  • Figure 6.25: Global Skin/Dermal Substitutes Market, by Types, 2018-2024
  • Figure 6.26: Global Wound Care Allograft Market, 2018-2024
  • Figure 6.27: Global Wound Care Xenograft Market, 2018-2024
  • Figure 6.28: Global Wound Care Placenta/Amniotic Tissue Market, 2018-2024
  • Figure 6.29: Global Wound Care Bioengineered and Synthetic Skin Market, 2018-2024
  • Figure 6.30: Global Wound Care Growth Factors Market, $Million, 2018-2024
  • Figure 6.31: Global Wound Care Topical Agents Market, $Million, 2018-2024
  • Figure 6.32: Global Hyperbaric Oxygen Therapy Market, $Million, 2018-2024
  • Figure 6.33: Global Ultrasound Mist and Electrical Simulation Market, $Million, 2018-2024
  • Figure 7.1: Wound Treatment Scenario
  • Figure 7.2: Global Advanced Wound Care Market, by Wound Type, 2018 and 2024
  • Figure 7.3: Global Chronic Wound Care Market, $Million, 2018-2024
  • Figure 7.4: Global Chronic Wound Care Market, by Disease Types, 2018-2024
  • Figure 7.5: Global Pressure Ulcer Advanced Wound Care Market ($Million), 2018-2024
  • Figure 7.6: Global Venous Leg Ulcer Advanced Wound Care Market ($Million), 2018-2024
  • Figure 7.7: Global Diabetic Foot Ulcer Advanced Wound Care Market ($Million), 2018-2024
  • Figure 7.8: Global Acute Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.1: Advanced Wound Care Market, by regions, 2018 and 2024
  • Figure 8.2: Snapshot
  • Figure 8.3: North America Advanced Wound Management Market, by Products, 2018-2024
  • Figure 8.4: North America Advanced Wound Care Market ($Million), by Countries 2018-2024
  • Figure 8.5: Snapshot
  • Figure 8.6: The U.S. Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.7: Snapshot
  • Figure 8.8: Canada Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.9: Snapshot
  • Figure 8.10: Europe Advanced Wound Management Market, by Products, 2018-2024
  • Figure 8.11: Europe Advanced Wound Care Market ($Million), by Countries 2018-2024
  • Figure 8.12: Snapshot
  • Figure 8.13: UK Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.14: Snapshot
  • Figure 8.15: Germany Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.16: Snapshot
  • Figure 8.17: Asia-Pacific Advanced Wound Management Market, by Products, 2018-2024
  • Figure 8.18: Asia-Pacific Advanced Wound Care Market ($Million), by Countries 2018-2024
  • Figure 8.19: Snapshot
  • Figure 8.20: Japan Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.21: Snapshot
  • Figure 8.22: China Advanced Wound Care Market ($Million), 2018-2024
  • Figure 8.23: Snapshot
  • Figure 8.24: Rest-of-the-World Advanced Wound Management Market, by Products, 2018-2024
  • Figure 8.25: Rest-of-the-World Advanced Wound Care Market ($Million), by Countries 2018-2024
  • Figure 8.26: Snapshot
  • Figure 8.27: Brazil Advanced Wound Care Market ($Million), 2018-2024
  • Figure 9.1: 3M: Advanced Wound Care Product Portfolio
  • Figure 9.2: 3M, Overall Financials, 2016-2018
  • Figure 9.3: 3M, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.4: 3M, Total Sales Revenue (by Region), 2016-2018
  • Figure 9.5: 3M, Total Sales Revenue, 2016-2018
  • Figure 9.6: 3M: SWOT Analysis
  • Figure 9.7: Acelity: Advanced Wound Care Product Portfolio
  • Figure 9.8: Acelity, Overall Financials, 2016-2018
  • Figure 9.9: Acelity, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.10: Acelity (by Region), 2016-2018
  • Figure 9.11: Acelity, Total Sales Revenue, 2016-2018
  • Figure 9.12: Acelity: SWOT Analysis
  • Figure 9.13: B. Braun: Advanced Wound Care Product Portfolio
  • Figure 9.14: B. Braun, Overall Financials, 2016-2018
  • Figure 9.15: B. Braun, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.16: B. Braun (by Region), 2016-2018
  • Figure 9.17: B. Braun, Total Sales Revenue, 2016-2018
  • Figure 9.18: B. Braun: SWOT Analysis
  • Figure 9.19: Coloplast A/S: Advanced Wound Care Product Portfolio
  • Figure 9.20: Coloplast A/S, Overall Financials, 2016-2018
  • Figure 9.21: Coloplast A/S, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.22: Coloplast A/S (by Region), 2016-2018
  • Figure 9.23: Coloplast A/S, Total Sales Revenue, 2016-2018
  • Figure 9.24: Coloplast A/S: SWOT Analysis
  • Figure 9.25: ConvaTec Group PLC: Advanced Wound Care Product Portfolio
  • Figure 9.26: ConvaTec Group PLC, Overall Financials, 2016-2018
  • Figure 9.27: ConvaTec Group Plc, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.28: ConvaTec Group PLC (by Region), 2016-2018
  • Figure 9.29: ConvaTec Group PLC, Total Sales Revenue, 2016-2018
  • Figure 9.30: ConvaTec Group PLC: SWOT Analysis
  • Figure 9.31: Essity Aktiebolag: Advanced Wound Care Product Portfolio
  • Figure 9.32: Essity Aktiebolag, Overall Financials, 2016-2018
  • Figure 9.33: Essity Aktiebolag, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.34: Essity Aktiebolag (by Region), 2016-2018
  • Figure 9.35: Essity Aktiebolag, Total Sales Revenue, 2016-2018
  • Figure 9.36: Essity Aktiebolag: SWOT Analysis
  • Figure 9.37: Integra LifeSciences Corporation: Advanced Wound Care Product Portfolio
  • Figure 9.38: Integra LifeSciences Corporation, Overall Financials, 2016-2018
  • Figure 9.39: Integra LifeSciences Corporation, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.40: Integra LifeSciences Corporation (by Region), 2016-2018
  • Figure 9.41: Integra LifeSciences Corporation, Total Sales Revenue, 2016-2018
  • Figure 9.42: Integra LifeSciences Corporation: SWOT Analysis
  • Figure 9.43: Medline Industries, Inc.: Advanced Wound Care Product Portfolio
  • Figure 9.44: Medline Industries, Inc.: SWOT Analysis
  • Figure 9.45: Molnlycke Health Care AB: Advanced Wound Care Product Portfolio
  • Figure 9.46: Molnlycke Health Care AB: SWOT Analysis
  • Figure 9.47: MiMedX: Advanced Wound Care Product Portfolio
  • Figure 9.48: MiMedx: SWOT Analysis
  • Figure 9.49: Organogenesis Inc.: Advanced Wound Care Product Portfolio
  • Figure 9.50: Organogenesis Inc., Overall Financials, 2016-2018
  • Figure 9.51: Organogenesis Inc., Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.52: Organogenesis Inc., Total Sales Revenue, 2016-2018
  • Figure 9.53: Organogenesis Inc.: SWOT Analysis
  • Figure 9.54: Osiris Therapeutics: Wound Care Product Portfolio
  • Figure 9.55: Osiris Therapeutics, Overall Financials, 2016-2018
  • Figure 9.56: Osiris Therapeutics, Total Sales Revenue (by Segments and Products), 2016-2018
  • Figure 9.57: Osiris Therapeutics, Total Sales Revenue, 2016-2018
  • Figure 9.58: Osiris Therapeutics: SWOT Analysis
  • Figure 9.59: PAUL HARTMANN AG: Product Portfolio
  • Figure 9.60: PAUL HARTMANN AG, Overall Financials, 2016-2018
  • Figure 9.61: PAUL HARTMANN AG, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.62: PAUL HARTMANN AG (by Region), 2016-2018
  • Figure 9.63: PAUL HARTMANN AG, Total Sales Revenue, 2016-2018
  • Figure 9.64: PAUL HARTMANN AG: SWOT Analysis
  • Figure 9.65: Smith & Nephew Plc: Advanced Wound Care Product Portfolio
  • Figure 9.66: Smith & Nephew Plc, Overall Financials, 2016-2018
  • Figure 9.67: Smith & Nephew Plc, Total Sales Revenue (by Segment), 2016-2018
  • Figure 9.68: Smith & Nephew Plc (by Region), 2016-2018
  • Figure 9.69: Smith & Nephew Plc, Total Sales Revenue, 2016-2018
  • Figure 9.70: Smith & Nephew Plc: SWOT Analysis
目次
Product Code: BH011B

"Global Advanced Wound Care Market to Reach $11,059.3 Million by 2024, Reports BIS Research."

Key questions answered in the report:

  • How big is the advanced wound care market and what is its outlook for future?
  • What are the drivers and restraints of this market?
  • Which technologies dominate in this advanced wound care market?
  • What will be the growth of sub segments of the advanced wound care market (advanced dressings, NPWT, biologics) and their sub-categories (films, alginates, single use NPWT, allograft, and others)?
  • How will the advanced wound care market and its sub segments behave in different regions, and countries? What are the expected growth rates?
  • What are the characteristics (GDP, disease prevalence, regulations, and reimbursements) of countries that are major market for advanced wound care products?
  • What are the key developments in this market- mergers and acquisitions, product launches etc. in past 3 years?
  • Who are the dominant players in this market and its sub-segments?
  • What strategies are deployed by leading players to maintain market share?

Advanced Wound Care Market Forecast

The global advanced wound care market, by products, was valued to be $8,904.6 million in 2018 and is estimated to reach a market value of $11,059.3 million by 2024 at a CAGR of 3.62% from 2019 to 2024.

The market is subject to intense competition and the rising demand by the governments to reduce spending on healthcare is dragging the market growth. However, the future growth is expected to be driven by favorable demographic factors such as growing aging population and rising incidences of chronic wounds.

Expert Quote

"Emerging technologies such as crab shell bandages (involving usage of abundant proteins, chitin, complex hydrogels), bacteriophages, platelets, and stem cell therapy are expected to drive advanced wound care market in future. However, availability of these technologies in the market is a challenge for key players in the market as these products still needs to showcase incremental improvement from current advanced wound care technologies and in order to convince regulators across countries to reimburse these costly treatments such as stem cell therapy. It will take another 5-10 year for these emerging technologies to significantly capture market share from current technologies."

Scope of the Advanced Wound Care Market

The purpose of this study is to gain a holistic view of the global advanced wound care market in terms of various influencing factors, such as regional adoption trends, and key developments, among others. The scope of this report constitutes of an in-depth study of the market, including a thorough analysis of the products across different regions. The report includes an in-depth examination of the key ecosystem players and key strategies and developments taking place in this market. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

Market Segmentation

The report on global advanced wound care market tracks trends, industry participants, and quantifies technologies that facilitates wound healing in conditions where standard wound care therapies fails. These technologies are classified under advanced wound dressings, negative pressure wound therapy, wound biologics and an array of emerging technologies such as oxygen therapy, electric simulation, spray mist, and shockwave therapy.

Diving further deep, this report also discusses and quantifies the various underlying conditions for wounds, wound care global burden, and application of advanced wound care in the management of chronic and acute wounds.

The above analysis is conducted at a regional and country level and markets have been sized and forecasted by considering impact of various trends. Major industry participants and their products have been thoroughly analyzed and forecasts of their performance, market share, and growth rates have been provided. The report considers 2018 as the base year and forecasts the market for the period of 2019-2024.

Key Companies in the Advanced Wound Care Market

Acelity (3M), Smith and Nephew, Molnlycke, ConvaTec, Coloplast, Hartmann, Integra, BSN Medical, MiMedX, Medline and Organogenesis are some of the leading players in this market.

Table of Contents

Executive Summary

1. Product Definition

2. Scope of the Report

3. Research Methodology

  • 3.1. Research Methodology
  • 3.2. Data Sources
    • 3.2.1. Secondary Research Data Sources
    • 3.2.2. Primary Data Sources

4. Industry Analysis

  • 4.1. Industry Evolution
  • 4.2. Wound Management Cost and Supply Chain Analysis
  • 4.3. Legal and Regulatory Framework

5. Competitive Landscape

  • 5.1. Vendor Share Analysis
  • 5.2. Key Strategies and Developments
    • 5.2.1. Product Launch and Updates
    • 5.2.2. Mergers and Acquisitions
  • 5.3. Product Mapping
  • 5.4. Competitive Benchmark Mapping

6. Global Advanced Wound Care Market (by Product)

  • 6.1. Overview
  • 6.2. Advanced Wound Dressing
    • 6.2.1. Film Dressing
    • 6.2.2. Foam Dressing
    • 6.2.3. Hydrofiber Dressing
    • 6.2.4. Hydrocolloids Dressing
    • 6.2.5. Hydrogel Dressing
    • 6.2.6. Collagen Dressing
    • 6.2.7. Alginate Dressing
    • 6.2.8. Antimicrobial Dressing
  • 6.3. Negative Pressure Wound Therapies (NPWT Devices)
    • 6.3.1. Conventional Negative Pressure Wound Therapy
      • 6.3.1.1. Canisters
      • 6.3.1.2. Pumps
      • 6.3.1.3. Dressing Kits
    • 6.3.2. Single-Use Negative Pressure Wound Therapy
  • 6.4. Biologics
    • 6.4.1. Skin/Dermal Substitutes
      • 6.4.1.1. Allograft
      • 6.4.1.2. Xenograft
      • 6.4.1.3. Placenta/Amniotic Tissue
      • 6.4.1.4. Bioengineered skin/synthetic Substitutes
    • 6.4.2. Growth Factors
    • 6.4.3. Topical Agents
  • 6.5. Other Advanced Wound Care Products
    • 6.5.1. Hyperbaric Oxygen Therapy
    • 6.5.2. Ultrasonic Mist and Electrical Simulation Devices

7. Global Advance Wound Care Therapy Market (by Wound type)

  • 7.1. Overview
  • 7.2. Chronic Wounds
    • 7.2.1. Pressure Ulcer (PU)
    • 7.2.2. Venous Leg Ulcer (VLU)
    • 7.2.3. Diabetic Foot Ulcer (DFU)
  • 7.3. Acute Wounds

8. Global Advanced Wound Care Market (by Region)

  • 8.1. North America
    • 8.1.1. U.S.
    • 8.1.2. Canada
  • 8.2. Europe
    • 8.2.1. U.K.
    • 8.2.2. Germany
  • 8.3. Asia-Pacific
    • 8.3.1. Japan
    • 8.3.2. China
  • 8.4. Rest-of-the-World (RoW)
    • 8.4.1. Brazil

9. Company Profiles

  • 9.1. 3M
    • 9.1.1. Company Overview
    • 9.1.2. Role of 3M in the Global Advanced Wound Care Market
    • 9.1.3. Financials
    • 9.1.4. SWOT Analysis
  • 9.2. Acelity
    • 9.2.1. Company Overview
    • 9.2.2. Role of Acelity in the Global Advance Wound Care Market
    • 9.2.3. Financials
    • 9.2.4. SWOT Analysis
  • 9.3. B. Braun
    • 9.3.1. Company Overview
    • 9.3.2. Role of B. Braun in the Global Advance Wound Care Market
    • 9.3.3. Financials
    • 9.3.4. SWOT Analysis
  • 9.4. Coloplast A/S
    • 9.4.1. Company Overview
    • 9.4.2. Role of Coloplast A/S in the Global Advanced Wound Care Market
    • 9.4.3. Financials
    • 9.4.4. SWOT Analysis
  • 9.5. ConvaTec Group Plc
    • 9.5.1. Company Overview
    • 9.5.2. Role of ConvaTec Group Plc in the Global Advanced Wound Care Market
    • 9.5.3. Financials
    • 9.5.4. SWOT Analysis
  • 9.6. Essity Aktiebolag
    • 9.6.1. Company Overview
    • 9.6.2. Role of Essity Aktiebolag in the Global Advance Wound Care Market
    • 9.6.3. Financials
    • 9.6.4. SWOT Analysis
  • 9.7 Integra LifeSciences Corporation
    • 9.7.1. Company Overview
    • 9.7.2. Role of Integra LifeSciences Corporation in the Global Advance Wound Care Market
    • 9.7.3. Financials
    • 9.7.4. SWOT Analysis
  • 9.8. Medline Industries, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Role of Medline Industries, Inc. in the Global Advance Wound Care Market
    • 9.8.3. SWOT Analysis
  • 9.9. Molnlycke Health Care AB
    • 9.9.1. Company Overview
    • 9.9.2. Role of Molnlycke Health Care AB in the Global Advanced Wound Care Market
    • 9.9.3. SWOT Analysis
  • 9.10 MIMEDX GROUP, INC.
    • 9.10.1. Company Overview
    • 9.10.2. Role of MiMedX in the Global Advance Wound Care Market
    • 9.10.3. Mimedx: Financials
    • 9.10.4. SWOT Analysis
  • 9.11 Organogenesis Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Role of Organogenesis Inc. in the Global Advance Wound Care Market
    • 9.11.3. Financials
    • 9.11.4. SWOT Analysis
  • 9.12 Osiris Therapeutics Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Role of Osiris Therapeutics in the Global Advance Wound Care Market
    • 9.12.3. Financials
    • 9.12.4. SWOT Analysis
  • 9.13 PAUL HARTMANN AG
    • 9.13.1. Company Overview
    • 9.13.2. Role of PAUL HARTMANN AG in the Global Advance Wound Care Market
    • 9.13.3. Financials
    • 9.13.4. SWOT Analysis
  • 9.14 Smith & Nephew Plc
    • 9.14.1. Company Overview
    • 9.14.2. Role of Smith & Nephew Plc in the Global Advance Wound Care Market
    • 9.14.3. Financials
    • 9.14.4. SWOT Analysis
Back to Top